Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
0.8700
-0.3800 (-30.40%)
At close: Jan 14, 2026, 4:00 PM EST
0.9400
+0.0700 (8.05%)
After-hours: Jan 14, 2026, 6:56 PM EST
Decoy Therapeutics Market Cap
Decoy Therapeutics has a market cap or net worth of $5.55 million as of January 14, 2026. Its market cap has increased by 131.68% in one year.
Market Cap
5.55M
Enterprise Value
1.77M
1-Year Change
131.68%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since July 22, 2019, Decoy Therapeutics's market cap has decreased from $44.21M to $5.55M, a decrease of -87.44%. That is a compound annual growth rate of -27.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 7.98M | 92.66% |
| Dec 31, 2025 | 4.14M | 56.20% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.56% |
| Dec 30, 2022 | 3.49M | -84.44% |
| Dec 31, 2021 | 22.40M | 3.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 964.49B |
| Johnson & Johnson | 514.75B |
| AbbVie | 390.15B |
| UnitedHealth Group | 302.49B |
| AstraZeneca | 291.77B |
| Novartis AG | 272.12B |
| Merck & Co. | 268.70B |
| Novo Nordisk | 265.30B |